First published · Last updated
Safety and Effectiveness of Caplacizumab in Pediatric Patients With iTTP: Real-World Experience
A peer-reviewed journal article published 2026-09-01 reports real-world clinical experience with caplacizumab in children with immune TTP. The supplied excerpt included only publisher and content type and provided no study details or results.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 2/10
- Impact magnitude
- 2/10
- Positivity
- 5/10
- Urgency
- 2/10
Why it matters
The article addresses safety and effectiveness of a therapy in a pediatric rare-disease population, which is relevant to clinicians and researchers.

